Clinical Trials Logo

Clinical Trial Summary

To determine if statin therapy plus intravenous normal saline, in patients with chronic renal insufficiency undergoing angiography, is superior to placebo plus intravenous normal saline therapy in the prevention of CIN.


Clinical Trial Description

Due to the conflict in the available data, there are no practice guidelines that are established in order to prevent contrast-induced nephropathy (CIN). Our goal is to determine if statin therapy plus intravenous normal saline, in patients with chronic renal insufficiency undergoing angiography, is superior to placebo plus intravenous normal saline therapy in the prevention of CIN. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT01071993
Study type Interventional
Source University of Oklahoma
Contact
Status Terminated
Phase N/A
Start date March 2010
Completion date July 2013

See also
  Status Clinical Trial Phase
Enrolling by invitation NCT05530356 - Renal Hemodynamics, Energetics and Insulin Resistance: A Follow-up Study
Recruiting NCT01448889 - Normobaric Hyperoxygenation for Prevention of Contrast Induced Nephropathy N/A
Active, not recruiting NCT05026021 - Prediction of BKvirus Nephropathy Risk by the NEPHROVIR Method in Kidney Transplant Patients With BKvirus Viremia
Completed NCT02470247 - Interest of Remote Ischemic Preconditioning for Prevention of Contrast Medium-induced Nephropathy in High Risk Patients N/A
Recruiting NCT05511779 - Study to Confirm of the Safety and Tolerability of Brincidofovir in Subjects With BK Virus Infection (Viremia) After Kidney Transplantation Phase 2
Active, not recruiting NCT03620773 - Impact of Metabolic Surgery on Pancreatic, Renal and Cardiovascular Health in Youth With Type 2 Diabetes Phase 1/Phase 2
Active, not recruiting NCT03584217 - Renal HEIR Study: Renal Hemodynamics, Energetics and Insulin Resistance in Youth Onset Type 2 Diabetes Study Phase 1/Phase 2
Completed NCT03618420 - Copeptin in Adolescent Participants With Type 1 Diabetes and Early Renal Hemodynamic Function Phase 1/Phase 2
Completed NCT02575092 - The Relationship Between HHcy and Contrast-induced Nephropathy in Hypertensive Patients After Coronary Artery Diagnosis and Treatment Phase 2/Phase 3
Recruiting NCT05839314 - Effect of Huaier Granule on the Treatment of Idiopathic Membranous Nephropathy Phase 4
Completed NCT01638663 - Effect of the Aquaretic Tolvaptan on Nitric Oxide System (TORA) Phase 2
Completed NCT01213498 - The Effects of Atorvastatin on the Nitric Oxide-system in Patients With Non-diabetic Nephropathy Phase 2
Completed NCT01208701 - The Effects of Atorvastatin on the Nitrogen Oxide-system in Patients With Type 2 Diabetes and Nephropathy Phase 2
Completed NCT01214746 - The Effects of Atorvastatin on the Nitric Oxide-system in Healthy Young Man Phase 2
Active, not recruiting NCT00655330 - Probucol Combined With Valsartan in Reducing Proteinuria in Diabetes Nephropathy N/A
Completed NCT00308347 - A Research Study to Evaluate the Renal (Kidney) Protective Effects of Losartan in Patients With Non-insulin Dependent Diabetes (0954-147)(COMPLETED) Phase 3
Terminated NCT00579995 - A Prospective, Randomized TrialComparing Oral N-Acetylcysteine and Intravenous Sodium Bicarbonate N/A
Completed NCT05986474 - Development of Synthetic Medical Data Generation Technology to Predict Postoperative Complications
Recruiting NCT03886714 - Screening for Fabry Disease in Renal Transplantation
Recruiting NCT06325059 - The Role of Renal Progenitors and Polyploid Tubular Cell Response in Glomerular and Tubular Diseases N/A